AU2001262834A1 - Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition - Google Patents

Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition

Info

Publication number
AU2001262834A1
AU2001262834A1 AU2001262834A AU6283401A AU2001262834A1 AU 2001262834 A1 AU2001262834 A1 AU 2001262834A1 AU 2001262834 A AU2001262834 A AU 2001262834A AU 6283401 A AU6283401 A AU 6283401A AU 2001262834 A1 AU2001262834 A1 AU 2001262834A1
Authority
AU
Australia
Prior art keywords
bicalutamide
anastrozole
providing
pharmaceutical combination
aromatase inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262834A
Inventor
Ian Cockshott
Barrington Furr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001262834A1 publication Critical patent/AU2001262834A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001262834A 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition Abandoned AU2001262834A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0012293.7A GB0012293D0 (en) 2000-05-23 2000-05-23 Pharmaceutical combination
GB0012293 2000-05-23
PCT/SE2001/001163 WO2001089516A1 (en) 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition

Publications (1)

Publication Number Publication Date
AU2001262834A1 true AU2001262834A1 (en) 2001-12-03

Family

ID=9892040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262834A Abandoned AU2001262834A1 (en) 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition

Country Status (5)

Country Link
EP (1) EP1292297A1 (en)
JP (1) JP2003534279A (en)
AU (1) AU2001262834A1 (en)
GB (1) GB0012293D0 (en)
WO (1) WO2001089516A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2547339T3 (en) 2007-11-13 2015-10-05 Curadis Gmbh C-19 steroids for specific therapeutic uses
CN102988313A (en) * 2011-09-14 2013-03-27 北京以岭生物工程技术有限公司 Anastrozole dispersible tablet and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121152A1 (en) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "USE OF THE COMBINATION OF AN AROMATASE INHIBITOR WITH AN ANTIANDROGEN FOR PROPHYLAXIS AND THERAPY OF PROSTATE HYPERPLASIA"
ATE28864T1 (en) * 1982-07-23 1987-08-15 Ici Plc AMIDE DERIVATIVES.
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
EP0748220A4 (en) * 1994-01-21 1997-09-10 Sepracor Inc Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia

Also Published As

Publication number Publication date
WO2001089516A1 (en) 2001-11-29
JP2003534279A (en) 2003-11-18
GB0012293D0 (en) 2000-07-12
EP1292297A1 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
EP1085848A4 (en) Inhibitors of transcription factor nf-kappa b
HUP0201463A3 (en) Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect and their use
PL370447A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
SI1423381T1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AU4166400A (en) Alkenyl and alkynyl compounds as inhibitors of factor xa
EP1383743A4 (en) Dual inhibitors of pde 7 and pde 4
HUP0201872A2 (en) Steroid compounds and pharmaceutical compositions of the same
AU2002235520A1 (en) Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2003223601A1 (en) ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN Beta 4
AU2001273074A1 (en) Combinations of ssri and estrogenic agents
AU2001271163A1 (en) Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU2001288682A1 (en) Inhibition of cmv infection and dissemination
HUP0401687A3 (en) Acylsulfonamides as inhibitors of steroid sulfatase and pharmaceutical compositions containing them
IL140324A0 (en) Inhibition of transcription factor nf-kb
HK1053061A1 (en) Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
AU2001262834A1 (en) Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
AUPQ629000A0 (en) Inhibition of fungi
AU7601400A (en) Treatment and prevention of hepatic disorders
AU5673099A (en) Inhibitors of amyloid formation
AU3663700A (en) Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
AU2001268000A1 (en) Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition
AU2001268001A1 (en) Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition
AU2001271162A1 (en) Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition